Startseite
Almelo logo
Almelo

Über das Unternehmen

  • Firmenname (rechtlich): Almelo
  • Registrierungsland: India
  • Adresse: 8-2-120/45/A/2, Lane Opp: Mayfair Apartments, Road No:2, Banjarahills, Hyderabad 500 034, Telangana
Beschreibung:

DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP Almelo

Geschäftsaktivitäten

Vertrags- & Outsourcing-Dienstleistungen

Dienstleister

Zulassungs- & Marktanalyse-Dienstleistungen

Dienstleister

Labor- & Analysedienstleistungen

Dienstleister

Unsere Produkte & Dienstleistungen

Sell · Active Pharmaceutical Ingredients (APIs)
Dimethyl Fumarate - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Empagliflozin - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Vonoprazan Fumarate - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Pregabalin - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Ranolazine - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sitagliptin Phosphate - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Alfuzosin Hydrochloride - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Azilsartan Medoxomil Potassium - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Ropinirole Hydrochloride - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Prazosin Hydrochloride - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Doxazosin Mesylate - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Gadobutrol - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Dolutegravir Sodium - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Ziprasidone Mesylate - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Sugammadex Sodium - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Oclacitinib Maleate - Almelo
Sell · Active Pharmaceutical Ingredients (APIs)
Avibactam Sodium - Almelo

Certifications

CEP-Zertifikat

FDA

ISO 17020

GMP

DMF

Filter:
Sortieren nach:

    Keine Kommentare verfügbar.